Virus de la grippe
Les inhibiteurs du virus de la grippe sont des composés qui interfèrent avec la réplication et la propagation des virus de la grippe. Ces inhibiteurs sont essentiels pour rechercher des stratégies antivirales, comprendre le cycle de vie du virus de la grippe et développer des traitements et des vaccins efficaces. Les inhibiteurs de la grippe peuvent cibler différentes étapes du processus de réplication virale, y compris l'entrée virale, la réplication et la libération. Chez CymitQuimica, nous offrons une large gamme d'inhibiteurs de haute qualité du virus de la grippe pour soutenir vos recherches en virologie, maladies infectieuses et développement de médicaments antiviraux.
296 produits trouvés pour "Virus de la grippe"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Anti-Influenza agent 4
CAS :<p>Anti-Influenza agent 4 selectively inhibits A/Parma (EC50: 62 nM) and A/Roma (EC50: 150 nM) influenza strains.</p>Formule :C19H18N2O5SDegré de pureté :98.94% - 98.95%Couleur et forme :SolidMasse moléculaire :386.42NS1-IN-1
CAS :<p>NS1-IN-1: Potent NS1 inhibitor, antiviral, reduces viral proteins by inhibiting mTORC1 via TSC1-TSC2, limits replication.</p>Formule :C23H26N2O4Degré de pureté :98.71%Couleur et forme :SolidMasse moléculaire :394.46Laninamivir Octanoate Monohydrate
CAS :<p>Laninamivir Octanoate Monohydrate is a neuraminidase inhibitor.</p>Formule :C21H38N4O9Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :490.55(Rac)-CP-609754
CAS :<p>LNK754 is a farnesyltransferase inhibitor. It is used for the treatment of cancer and Alzheimer's disease.</p>Formule :C29H22ClN3O2Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :479.96Antiviral agent 43
CAS :<p>Antiviral agent 43 (compound 16) serves as a potent, orally active inhibitor of influenza A virus entry, demonstrating efficacy by inhibiting the replication of the influenza A strains VH04-H5N1 and PR8-H1N1 with EC50 values of 240 nM and 72 nM, respectively [1].</p>Formule :C17H22ClF3N2OCouleur et forme :SolidMasse moléculaire :362.82Cap-dependent endonuclease-IN-13
CAS :<p>Cap-dependent endonuclease-IN-13 is a potent inhibitor of cap-dependent endonuclease (CEN) and shows research potential against influenza virus infection (</p>Formule :C25H20F2N4O4SCouleur et forme :SolidMasse moléculaire :510.51Influenza virus-IN-6
CAS :<p>Influenza virus-IN-6 (Compound 35) serves as a potent inhibitor targeting the N-terminal domain of the polymerase acidic protein (PA N ) endonuclease subunit of</p>Formule :C27H26ClNO7Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :511.95L-742001 Hydrochloride
CAS :<p>L-742001 Hydrochloride is an RNA polymerase inhibitor.</p>Formule :C23H25Cl2NO4Couleur et forme :SolidMasse moléculaire :450.36DU-34569 Maleate
CAS :<p>DU-34569 Maleate, an antiviral agent, acts against influenza A, parainfluenza Sendai, coxsackie A21, and rhinovirus.</p>Formule :C18H27NO4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :321.41RO-7
CAS :<p>RO-7 is a next-generation polymerase (PA) endonuclease influenza A and B viruses inhibitor.</p>Formule :C24H20F3N3O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :487.49JNJ4796
CAS :<p>JNJ4796 is an oral fusion inhibitor that neutralizes influenza A group 1 by blocking HA-mediated fusion, mimicking bnAbs.</p>Formule :C28H27N9O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :537.57Tirfipiravir
CAS :<p>Tirapiravir is an antiviral nucleoside analog that exhibits activity against both the novel coronavirus and influenza virus [1].</p>Formule :C14H17N3O8Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :355.3EHNA hydrochloride
CAS :<p>EHNA hydrochloride is a PDE2 and ADA inhibitor with anticancer activity, increasing intracellular adenosine concentration in a treatment time-dependent manner.</p>Formule :C14H24ClN5ODegré de pureté :98%Couleur et forme :SolidMasse moléculaire :313.83Antiviral agent 35
CAS :<p>Antiviral agent 35 (compound 4d) serves as a potent orally active inhibitor of the influenza virus, targeting early stages of viral replication.</p>Formule :C23H18N2O4SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :418.47XSJ2-46
CAS :<p>XSJ2-46, a 5'-amino NI analog, is an antiviral agent possessing anti-Zika virus properties and demonstrates reasonable inhibition of RNA-dependent RNA</p>Formule :C25H24ClF3N6O3Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :548.953,4'-Dihydroxyflavone
CAS :<p>3,4'-Dihydroxyflavone (3,4'-DHF) is an oral active flavonoid. 3,4'-Dihydroxyflavone (3,4'-DHF) shows antiviral activity against Influenza A virus.</p>Formule :C15H10O4Degré de pureté :98.33%Couleur et forme :SolidMasse moléculaire :254.243M-011
CAS :<p>3M-011: potent TLR7/8 agonist, cytokine inducer, enhances radiotherapy, fights H3N2, and has anti-tumor effects.</p>Formule :C18H25N5O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :391.49EBOV-IN-1
CAS :<p>EBOV-IN-1 is an adamantane dipeptide piperazine inhibitor of Ebola virus (EBOV) that inhibits EBOV infection and suppresses pseudotypic EBOV infection.</p>Formule :C34H43N3O5Degré de pureté :98.62% - 98.92%Couleur et forme :SolidMasse moléculaire :573.72Massarilactone H
CAS :<p>Massarilactone H, a polyketide, is a neuraminidase inhibitor, with an IC 50 of 8.18 µM .</p>Formule :C11H12O5Couleur et forme :SolidMasse moléculaire :224.21Flutimide
CAS :<p>Flutimide: Endonuclease inhibitor, IC50 = 3μM, for research on acute respiratory diseases like influenza.</p>Formule :C12H18N2O3Couleur et forme :SolidMasse moléculaire :238.28Saussureamine C
CAS :<p>Saussureamine C is an inhibitor of H274Y and N294S mutants.</p>Formule :C19H26N2O5Couleur et forme :SolidMasse moléculaire :362.42Neuraminidase-IN-11
<p>Neuraminidase-IN-11 (15e) inhibits H1N1 (IC50: 4.7nM), H5N1 (8.46nM), H5N8 viruses (1.5nM) selectively & potently.</p>Couleur et forme :SolidNeuraminidase-IN-4
<p>Neuraminidase-IN-4 inhibits neuraminidase (EC50: 1.59 μM) and has strong anti-H5N1 activity.</p>Formule :C21H20N2O6SCouleur et forme :SolidMasse moléculaire :428.46Carbodine
CAS :<p>Carbodine is an antiviral targeting CTP synthetase, effective against influenza A0/PR-8/34 and A2/Aichi/2/68.</p>Formule :C10H15N3O4Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :241.24RdRP-IN-5
CAS :<p>RdRP-IN-5 (compound 20), a potent inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), has potential application in influenza research [1].</p>Formule :C23H21N3O5Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :419.43Cap-dependent endonuclease-IN-17
CAS :<p>CEN inhibitor IN-17 targets influenza A/H3N2; IC50: 1.29 μM. From patent CN112898346A, DSC701.</p>Formule :C24H20F2N3O7PSCouleur et forme :SolidMasse moléculaire :563.47UNC0638 hydrate
CAS :<p>UNC0638 hydrate selectively inhibits G9a and GLP histone methyltransferases with IC50 values of 15 nM and 19 nM, respectively. It is effective in inhibiting invasion and migration of TNBC cells in vitro. Additionally, UNC0638 hydrate acts as an inhibitor of EHMT1/2 and induces the expression of fetal hemoglobin (HbF) in cultures of human erythroid progenitor cells. Furthermore, it exhibits antiviral activity against FMDV (foot-and-mouth disease virus) and VSV (vesicular stomatitis virus), demonstrating remarkable potency and selectivity across various epigenetic and non-epigenetic targets.</p>Formule :C30H49N5O3Couleur et forme :SolidMasse moléculaire :527.74Laninamivir trifluoroacetate
CAS :<p>Laninamivir trifluoroacetate, a long-acting antiviral, treats and prevents Influenza A and B via nasal spray.</p>Formule :C15H23F3N4O9Degré de pureté :98%Couleur et forme :SolidMasse moléculaire :460.363Neuraminidase-IN-18
CAS :<p>Neuraminidase-IN-18 (compound N5), a novel polyheterocyclic neuraminidase (NA) inhibitor, demonstrates significant inhibitory activity against H5N1 NA, with an IC 50 of 0.14 μM against the wild-type H5N1 NA and 0.27 μM against the H5N1-H274Y mutant NA. This compound effectively binds to NAs, inhibiting influenza virus replication at the cellular level [1].</p>Formule :C22H18FN3O3SCouleur et forme :SolidMasse moléculaire :423.46AV-5080
CAS :<p>AV-5080 is an orally active neuraminidase (neuraminidase) inhibitor that is utilized in the research of both Type A and Type B influenza viruses.</p>Formule :C15H25FN4O4Couleur et forme :SolidMasse moléculaire :344.38VV261
CAS :<p>VV261 is an orally active inhibitor of the Influenza Virus. It exhibits activity against the Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) and the Lymphocytic Choriomeningitis Virus (LCMV), with EC50 values of 0.89 and 0.15, respectively.</p>Formule :C28H34FN3O11Couleur et forme :SolidMasse moléculaire :607.58Cap-dependent endonuclease-IN-5
CAS :<p>Cap-dependent endonuclease-IN-5 inhibits CEN and fights influenza with low toxicity and good in vivo properties.</p>Formule :C27H21F2N3O4S2Couleur et forme :SolidMasse moléculaire :553.60cis-RdRP-IN-5
<p>Cis-RdRP-IN-5 is an effective inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), employed in influenza virus research.</p>Formule :C23H21N3O5Couleur et forme :SolidMasse moléculaire :419.43Anti-Influenza agent 3
<p>Compound 11h: Potent, low-toxicity anti-influenza, inhibits M2 ion channels. EC50: 3.29μM (H3N2), 2.45μM (H1N1).</p>Formule :C16H22ClNOSCouleur et forme :SolidMasse moléculaire :311.87Cap-dependent endonuclease-IN-10
CAS :<p>Cap-dependent endonuclease-IN-10, with low toxicity & good stability, effectively inhibits flu viruses and shows promise against A, B, C types.</p>Formule :C25H18F2N4O5SCouleur et forme :SolidMasse moléculaire :524.50Cap-dependent endonuclease-IN-2
<p>Cap-dependent endonuclease-IN-2 strongly blocks influenza A virus RNA polymerase; it's a CEN inhibitor.</p>Formule :C30H24FN3O7SCouleur et forme :SolidMasse moléculaire :589.59RdRP-IN-4
<p>RdRP-IN-4, an oral arylbenzohydrazide, inhibits influenza A/B by targeting PB1 of RdRP, with EC50s of 53 nM (H1N1) and 20 nM (Flu B), and aids infected mice.</p>Formule :C17H17Br2N3O2Couleur et forme :SolidMasse moléculaire :455.14Cap-dependent endonuclease-IN-6
CAS :<p>Cap-dependent endonuclease-IN-6 (compound 13) is a Cap-dependent endonuclease (CEN) inhibitor that inhibits influenza virus.</p>Formule :C23H21N3O3SCouleur et forme :SolidMasse moléculaire :419.5trans-RdRP-IN-5
<p>Trans-RdRP-IN-5 is a potent inhibitor of the influenza virus RNA-dependent RNA polymerase (RdRP), with applications in influenza virus research.</p>Formule :C23H21N3O5Couleur et forme :SolidMasse moléculaire :419.43Cap-dependent endonuclease-IN-7
CAS :<p>Cap-dependent endonuclease-IN-7, a potent CEN inhibitor, blocks viral mRNA synthesis and virus spread, with research use for influenza A, B, C.</p>Formule :C36H28FN3O7SCouleur et forme :SolidMasse moléculaire :665.69Cap-dependent endonuclease-IN-14
CAS :<p>Cap-dependent endonuclease-IN-14 hinders CEN and could treat influenza virus infections. (Patent CN113620948A, compound 1-c).</p>Formule :C30H23FN2O6SCouleur et forme :SolidMasse moléculaire :558.58Cap-dependent endonuclease-IN-25
CAS :<p>Cap-dependent endonuclease-IN-25 is a potent inhibitor of CEN, useful in studying Orthomyxoviridae viruses. (See WO2020075080A1, compound 4.)</p>Formule :C25H25N3O3Couleur et forme :SolidMasse moléculaire :415.48Cap-dependent endonuclease-IN-1
CAS :<p>Cap-dependent endonuclease-IN-1: potent, oral inhibitor with antiviral properties against influenza.</p>Formule :C27H22F2N2O6SDegré de pureté :98.88% - 99.09%Couleur et forme :SolidMasse moléculaire :540.54UH15-38
CAS :<p>UH15-38 is a potent and selective RIPK3 inhibitor that blocks necroptosis in alveolar epithelial cells triggered by IAV, useful for studying lung inflammation.</p>Formule :C26H27N5O2Degré de pureté :99.85%Couleur et forme :SolidMasse moléculaire :441.53FGI-106 tetrahydrochloride
CAS :<p>FGI-106 tetrahydrochloride demonstrates potent inhibitory activity across a broad spectrum of viruses, including those causing hemorrhagic fevers such as Ebola</p>Formule :C28H42Cl4N6Degré de pureté :99.68%Couleur et forme :SolidMasse moléculaire :604.48Cap-dependent endonuclease-IN-9
CAS :<p>Cap-dependent endonuclease-IN-9, a strong influenza inhibitor, shows low toxicity, good pharmacokinetics, and dynamic action.</p>Formule :C29H22F2N4O7SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :608.57
